Payden & Rygel Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$29M |
| 2 |
Ventas
VTR
|
+$13.1M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$12.5M |
| 4 |
Microsoft
MSFT
|
+$11.5M |
| 5 |
Costco
COST
|
+$9.03M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$86.2M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$37.9M |
| 3 |
VanEck JP Morgan EM Local Currency Bond ETF
EMLC
|
+$19M |
| 4 |
Corteva
CTVA
|
+$15.8M |
| 5 |
T-Mobile US
TMUS
|
+$15.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.88% |
| 2 | Financials | 14.47% |
| 3 | Healthcare | 12.33% |
| 4 | Industrials | 12.01% |
| 5 | Miscellaneous | 9.09% |
No holdings matched the selected filter criteria.
Similar funds
Payden & Rygel's Q2 2026 Portfolio in Review
As of Q2 2026, Payden & Rygel held 142 positions worth $1.3B, up 0.3% from $1.3B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Payden & Rygel withdrew a net $85.5M in Q2 2026, closing 11 positions and reducing 12 holdings. Its most notable exit was iShares JPMorgan USD Emerging Markets Bond ETF, an estimated $86.2M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Payden & Rygel opened a new position in Ventas worth $13.7M.
- Payden & Rygel's largest Q2 2026 buy was Ventas: 154,140 shares worth $13.7M.
- Payden & Rygel added most to Apple in Q2 2026, an estimated $29M increase.
- Payden & Rygel's biggest Q2 2026 reduction was VanEck JP Morgan EM Local Currency Bond ETF, cutting an estimated $19M.
- Payden & Rygel fully exited iShares JPMorgan USD Emerging Markets Bond ETF in Q2 2026, selling an estimated $86.2M.
- Payden & Rygel's ten largest holdings make up 29% of its $1.3B portfolio in Q2 2026.
- Payden & Rygel opened 28 new positions and closed 11 in Q2 2026.
- Payden & Rygel's portfolio value rose 0.3% quarter-over-quarter to $1.3B.
Based on Payden & Rygel's 13F filing for Q2 2026, filed 31 Jul 2026.